Valuation (86%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 10.93 | N/A |
| PEG Ratio (TTM) | 1.09 | N/A |
| P/S Ratio (TTM) | 1.88 | N/A |
| P/B Ratio (TTM) | 0.68 | N/A |
| P/FCF Ratio (TTM) | 6.17 | N/A |
| Price to 5YR AVG Earnings Ratio | 11.10 | N/A |
| Price to 5YR AVG FCF Ratio | 1.47 | N/A |
Profitability (28%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.50% | N/A |
| ROE (TTM) | 5.91% | N/A |
| Net Profit Margin (TTM) | 17.24% | N/A |
| ROIC 5YR AVG | 1.72% | N/A |
Growth (68%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 235.94% | -44.06% | 47.13% |
| Revenue | -0.05% | 14.49% | 14.41% |
| Net Income | 309.52% | -9.65% | 166.69% |
| Cash Flow | 1,204.36% | 240.14% | 150.79% |
Health (35%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.53 | N/A |
| Quick Ratio (TTM) | 1.53 | N/A |
| D/E Ratio (TTM) | 3.06 | N/A |
| Interest Coverage (TTM) | 1.14 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 0.41 | N/A |
| LTL to 5YR AVG FCF | 5.67 | N/A |
| Shares Outstanding Growth 5YR AVG | 15.49% | N/A |